Viewing Study NCT02275156


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT02275156
Status: COMPLETED
Last Update Posted: 2022-11-07
First Post: 2014-07-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hyperlipidemia View
None Mixed Dyslipidemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Subjects with normal renal function or severe renal impairment (RI) … View